Liu J Y JY - OmicsDI

Show results for

Unknown (1074)
Proteomics (24)
Genomics (19)
Metabolomics (12)
Transcriptomics (10)

Organisms

Homo sapiens (29)
Mus musculus (9)
Schizophyllum commune H4-8 (9)
Mycobacterium tuberculosis SP7 (9)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (9)
Oryza sativa Japonica Group (9)
Rabbit calicivirus (9)
Crotalus durissus terrificus (9)
Eriocheir sinensis (9)
Candidatus Endoriftia persephonae (9)
Mycobacterium tuberculosis SP10 (9)
Mycobacterium tuberculosis SP13 (9)
Cotesia typhae (9)
Mycobacterium tuberculosis SP22 (9)
Cepaea nemoralis (9)
Enterobacter ludwigii (9)
Trichoderma asperellum CBS 433.97 (9)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (9)
Nakaseomyces glabratus (9)
Olea europaea (9)
Branchiostoma belcheri (1)
Macaca mulatta (1)
Oryza sativa Japonica Group (1)
Cyanobacteriota (1)
Aspergillus oryzae (1)
Weissella confusa (1)
Enterobacter hormaechei (1)
Weissella paramesenteroides (1)
Tetragenococcus halophilus (1)
Severe acute respiratory syndrome coronavirus 2 (1)

Repository

EGA (18)
iProX (14)
biostudies-arrayexpress (11)
MetaboLights (10)
pride (9)
GNPS (2)
MassIVE (1)

Tissue

Fibroblast (2)
Blood serum (2)
Cell culture (2)
Epithelial cell (2)
Blood plasma (1)
Liver (1)

Disease

Disease free (2)

Technology Type

Mass Spectrometry (9)
Mass spectrometry (8)
Shotgun proteomics (8)
Affinity purification coupled with mass spectrometry proteomics (3)
Illumina HiSeq 2500 (ILLUMINA), Illumina HiSeq 4000 (ILLUMINA) (1)
NMR spectroscopy (1)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
Illumina HiSeq 2000 (1)
LCQ Classic (1)
LTQ FT (1)
LTQ Orbitrap Velos (1)
Q Exactive (1)
MALDI MS (Imaging MS) (1)
LMJ-SSP/ESI MS (Imaging MS) (1)
MS Imaging - (1)
Liquid Chromatography MS - positive (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (8)
2022 (6)
2016 (5)
2021 (3)
2018 (3)
2015 (2)
2012 (2)
2014 (2)
2013 (1)
2009 (1)
2026 (1)
2025 (1)
2019 (1)
2024 (1)
2020 (1)
2017 (1)

CHEBI ID

CHEBI:35038 (3)
CHEBI:34687 (3)
CHEBI:16359 (3)
CHEBI:64563 (3)
CHEBI:28865 (3)
CHEBI:143757 (2)
CHEBI:182784 (2)
CHEBI:195271 (2)
CHEBI:143745 (2)
CHEBI:139138 (2)
CHEBI:10136 (2)
CHEBI:34494 (2)
CHEBI:44526 (2)
CHEBI:27781 (2)
CHEBI:75542 (2)
CHEBI:80774 (2)
CHEBI:173703 (2)
CHEBI:16755 (2)
CHEBI:17568 (2)
CHEBI:16704 (2)
CHEBI:55328 (2)
CHEBI:17368 (2)
CHEBI:20067 (2)
CHEBI:27432 (2)
CHEBI:73858 (2)
CHEBI:116314 (2)
CHEBI:75342 (2)
CHEBI:27997 (2)
CHEBI:17154 (2)
CHEBI:16196 (2)

Metabolite Name

Tris(2-butoxyethyl) phosphate (3)
Cholic acid (3)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Dibutyl phthalate (DBP) (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
Elaidic acid (2)
Monoolein (2)
Lyso-PC(16:0) (2)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
Chenodeoxycholic acid (2)
Myristoleic acid (2)
Taurocholic acid (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
9(10)-EpOME (2)
Uracil (2)
Hypoxanthine (2)
Uridine (2)
NCGC00168953-02_C47H76O17_(3beta,5xi,9xi,22beta)-22,24-Dihydroxyolean-12-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-alpha-L-arabinopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid (1)
Sodium taurochenodeoxycholate (1)
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(R)-4-((3R,4R,5S,8S,9S,10R,13R,14S,17R)-3,4-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
3beta-Hydroxy-5-cholenoic acid (1)
Asparatate (1)
2-((4R)-4-((3R,5R,6S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid (1)
2-((R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid (1)
Diphenylphosphate|Diphenyl hydrogen phosphate (1)
Methyl 2-(3-oxo-2-pentylcyclopentyl)acetate (1)
Dodecanoylcarnitine (1)

Study type

RNA-seq of coding RNA (6)
RNA-seq of non coding RNA (2)
Other (1)
ChIP-seq (1)
Methylation profiling by array (1)

Release Date

2022 (133)
2021 (129)
2023 (116)
2020 (104)
2024 (96)
2025 (95)
2016 (70)
2018 (67)
2015 (55)
2017 (55)
2019 (51)
2014 (39)
2013 (23)
2012 (20)
2011 (13)
2026 (6)
2009 (4)
2010 (4)
2006 (2)
2008 (1)
2004 (1)
2000 (1)

Lab affiliation

Wiita Lab, Department of Laboratory Medicine, University of California San Francisco, USA (2)
Shanghai Center for Systems Biomedicine Shanghai Jiao Tong University (2)
Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia; Biomolecular Discovery Research Centre, Macquarie University, Sydney, NSW, Australia (1)
Aging Institute, University of Pittsburgh School of Medicine/UPMC (1)
Institute of Model Animal of Wuhan University, Wuhan, China. (1)
Obstetrics & Gynecology Institute, Institute of Metabolism and Integrative Biology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China (1)
Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, Nanchang, China. (1)

Previous page
1 / 114
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 114
Next page

Sort by:

Relevance

Page size

Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in mice.

Not available

S-EPMC6076272 | biostudies-literature

Molecular characterization revealed the role of thaumatin-like proteins of <i>Rhizoctonia solani</i> AG4-JY in inducing maize disease resistance.

Not available

S-EPMC11135045 | biostudies-literature

Active transport of cytoophidia in Schizosaccharomyces pombe.

Not available

S-EPMC6292696 | biostudies-literature

The profibrotic effects of MK-8617 on tubulointerstitial fibrosis mediated by the KLF5 regulating pathway.

Not available

S-EPMC6902673 | biostudies-literature

Comparative metabolomic analysis of exudates of microcystin-producing and microcystin-free Microcystis aeruginosa strains

Cyanobacterial harmful algal blooms (cHABs) dominated by Microcystis aeruginosa threaten the ecological integrity and beneficial uses of lakes globally. In addition to producing hepatotoxic microcystins (MC), M. aeruginosa exudates (MaE) contain various compounds with demonstrat...

2023-01-16 | MTBLS6603 | MetaboLights

GNPS - Molecular networking as a dereplication strategy -Figure 4

Molecular networking as a dereplication strategy. Yang JY, Sanchez LM, Rath CM, Liu X, Boudreau PD, Bruns N, Glukhov E, Wodtke A, de Felicio R, Fenner A, Wong WR, Linington RG, Zhang L, Debonsi HM, Gerwick WH, Dorrestein PC. J Nat Prod. 2013 Sep 27;76(9):1686-99. doi: 10.1021/np400413s PubMedID: 240...

ORGANISM(S): Data From Multiple Bacteria

2014-02-11 | MSV000078547 | GNPS

In plaque-mass spectrometry imaging of a bloom-forming alga during viral infection reveals a metabolic shift towards odd-chain fatty acid lipids (Imaging MS assays)

Tapping into the metabolic cross-talk between a host and its virus can reveal unique strategies employed during infection. Viral infection is a dynamic process that generates an evolving metabolic landscape. Gaining a continuous view into the infection process is highly challenging and is limited...

2018-11-29 | MTBLS769 | MetaboLights

Elk-1 associates with the mitochondrial permeability transition pore complex in neurons.

Not available

S-EPMC1458810 | biostudies-literature

GNPS - Molecular networking as a dereplication strategy-Figure 3

ORGANISM(S): Six Distinct Collections Of Cyanobacteria

2014-02-11 | MSV000078548 | GNPS

Upregulation of miRNA-130a Represents Good Prognosis in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Prospective Study.

Not available

S-EPMC4753881 | biostudies-literature